nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—AR—polycystic ovary syndrome	0.33	0.398	CbGaD
Cyproterone acetate—CYP19A1—polycystic ovary syndrome	0.276	0.333	CbGaD
Cyproterone acetate—NR3C1—polycystic ovary syndrome	0.224	0.27	CbGaD
Cyproterone acetate—CYP19A1—follicular fluid—polycystic ovary syndrome	0.0323	0.339	CbGeAlD
Cyproterone acetate—CYP19A1—corpus luteum—polycystic ovary syndrome	0.0186	0.195	CbGeAlD
Cyproterone acetate—CYP19A1—ovarian follicle—polycystic ovary syndrome	0.0145	0.153	CbGeAlD
Cyproterone acetate—CYP19A1—Ovarian Infertility Genes—GDF9—polycystic ovary syndrome	0.00395	0.0615	CbGpPWpGaD
Cyproterone acetate—NR3C1—urine—polycystic ovary syndrome	0.0039	0.041	CbGeAlD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—SHBG—polycystic ovary syndrome	0.00195	0.0305	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—TMF1—polycystic ovary syndrome	0.00176	0.0275	CbGpPWpGaD
Cyproterone acetate—Medroxyprogesterone Acetate—HSD3B2—polycystic ovary syndrome	0.00167	0.243	CrCbGaD
Cyproterone acetate—CYP19A1—Ovarian Infertility Genes—LHCGR—polycystic ovary syndrome	0.00151	0.0236	CbGpPWpGaD
Cyproterone acetate—CYP19A1—endometrium—polycystic ovary syndrome	0.00144	0.0151	CbGeAlD
Cyproterone acetate—AR—adrenal cortex—polycystic ovary syndrome	0.00143	0.015	CbGeAlD
Cyproterone acetate—CYP19A1—uterus—polycystic ovary syndrome	0.00133	0.0139	CbGeAlD
Cyproterone acetate—CYP19A1—adipose tissue—polycystic ovary syndrome	0.0013	0.0136	CbGeAlD
Cyproterone acetate—AR—endometrium—polycystic ovary syndrome	0.00127	0.0134	CbGeAlD
Cyproterone acetate—CYP19A1—Metabolism of steroid hormones and vitamin D—SRD5A1—polycystic ovary syndrome	0.00127	0.0198	CbGpPWpGaD
Cyproterone acetate—CYP19A1—FSH signaling pathway—FSHR—polycystic ovary syndrome	0.00127	0.0198	CbGpPWpGaD
Cyproterone acetate—NR3C1—embryo—polycystic ovary syndrome	0.00126	0.0133	CbGeAlD
Cyproterone acetate—CYP19A1—Metabolism of steroid hormones and vitamin D—STAR—polycystic ovary syndrome	0.00121	0.0189	CbGpPWpGaD
Cyproterone acetate—Ethynodiol—PGR—polycystic ovary syndrome	0.00121	0.176	CrCbGaD
Cyproterone acetate—AR—uterus—polycystic ovary syndrome	0.00117	0.0123	CbGeAlD
Cyproterone acetate—CYP19A1—adrenal gland—polycystic ovary syndrome	0.00116	0.0122	CbGeAlD
Cyproterone acetate—AR—pituitary gland—polycystic ovary syndrome	0.00115	0.0121	CbGeAlD
Cyproterone acetate—AR—adipose tissue—polycystic ovary syndrome	0.00115	0.0121	CbGeAlD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—GNRH1—polycystic ovary syndrome	0.00112	0.0175	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Ovarian Infertility Genes—FSHR—polycystic ovary syndrome	0.00111	0.0173	CbGpPWpGaD
Cyproterone acetate—CYP19A1—female gonad—polycystic ovary syndrome	0.00108	0.0114	CbGeAlD
Cyproterone acetate—NR3C1—adrenal cortex—polycystic ovary syndrome	0.00103	0.0109	CbGeAlD
Cyproterone acetate—CYP19A1—Metabolism of steroid hormones and vitamin D—HSD3B1—polycystic ovary syndrome	0.00103	0.0161	CbGpPWpGaD
Cyproterone acetate—AR—adrenal gland—polycystic ovary syndrome	0.00103	0.0108	CbGeAlD
Cyproterone acetate—CYP19A1—endocrine gland—polycystic ovary syndrome	0.00101	0.0106	CbGeAlD
Cyproterone acetate—CYP19A1—Endogenous sterols—CYP11A1—polycystic ovary syndrome	0.000968	0.0151	CbGpPWpGaD
Cyproterone acetate—AR—female gonad—polycystic ovary syndrome	0.00096	0.0101	CbGeAlD
Cyproterone acetate—AR—vagina—polycystic ovary syndrome	0.000954	0.01	CbGeAlD
Cyproterone acetate—CYP19A1—Metabolism of steroid hormones and vitamin D—LHB—polycystic ovary syndrome	0.000939	0.0147	CbGpPWpGaD
Cyproterone acetate—Medroxyprogesterone Acetate—AKR1C3—polycystic ovary syndrome	0.000924	0.134	CrCbGaD
Cyproterone acetate—NR3C1—endometrium—polycystic ovary syndrome	0.000923	0.0097	CbGeAlD
Cyproterone acetate—CYP19A1—Metabolism of steroid hormones and vitamin D—HSD3B2—polycystic ovary syndrome	0.000918	0.0143	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Endogenous sterols—CYP17A1—polycystic ovary syndrome	0.0009	0.014	CbGpPWpGaD
Cyproterone acetate—AR—endocrine gland—polycystic ovary syndrome	0.000893	0.00939	CbGeAlD
Cyproterone acetate—Megestrol acetate—PGR—polycystic ovary syndrome	0.000881	0.128	CrCbGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—INSR—polycystic ovary syndrome	0.000879	0.0137	CbGpPWpGaD
Cyproterone acetate—NR3C1—uterus—polycystic ovary syndrome	0.00085	0.00894	CbGeAlD
Cyproterone acetate—NR3C1—pituitary gland—polycystic ovary syndrome	0.000835	0.00878	CbGeAlD
Cyproterone acetate—NR3C1—adipose tissue—polycystic ovary syndrome	0.000831	0.00874	CbGeAlD
Cyproterone acetate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—ATF1—polycystic ovary syndrome	0.000811	0.0127	CbGpPWpGaD
Cyproterone acetate—NR3C1—adrenal gland—polycystic ovary syndrome	0.000746	0.00784	CbGeAlD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—polycystic ovary syndrome	0.000733	0.0114	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP11A1—polycystic ovary syndrome	0.000725	0.0113	CbGpPWpGaD
Cyproterone acetate—NR3C1—female gonad—polycystic ovary syndrome	0.000695	0.00731	CbGeAlD
Cyproterone acetate—AR—Nuclear Receptors—PGR—polycystic ovary syndrome	0.000693	0.0108	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—SLC2A4—polycystic ovary syndrome	0.000692	0.0108	CbGpPWpGaD
Cyproterone acetate—NR3C1—vagina—polycystic ovary syndrome	0.000691	0.00726	CbGeAlD
Cyproterone acetate—CYP19A1—Ovarian Infertility Genes—PGR—polycystic ovary syndrome	0.000684	0.0107	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP17A1—polycystic ovary syndrome	0.000674	0.0105	CbGpPWpGaD
Cyproterone acetate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—GNAS—polycystic ovary syndrome	0.000653	0.0102	CbGpPWpGaD
Cyproterone acetate—NR3C1—endocrine gland—polycystic ovary syndrome	0.000647	0.0068	CbGeAlD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—CAMK2D—polycystic ovary syndrome	0.0006	0.00935	CbGpPWpGaD
Cyproterone acetate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NAMPT—polycystic ovary syndrome	0.000591	0.00921	CbGpPWpGaD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—IGFBP1—polycystic ovary syndrome	0.000588	0.00917	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—LIFR—polycystic ovary syndrome	0.000554	0.00863	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—PGR—polycystic ovary syndrome	0.000547	0.00854	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptors—PGR—polycystic ovary syndrome	0.000525	0.00819	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—RUNX3—polycystic ovary syndrome	0.00052	0.00811	CbGpPWpGaD
Cyproterone acetate—Medroxyprogesterone Acetate—PGR—polycystic ovary syndrome	0.000513	0.0747	CrCbGaD
Cyproterone acetate—Megestrol acetate—NR3C1—polycystic ovary syndrome	0.00049	0.0713	CrCbGaD
Cyproterone acetate—Medroxyprogesterone Acetate—SHBG—polycystic ovary syndrome	0.00048	0.0699	CrCbGaD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—TFRC—polycystic ovary syndrome	0.000467	0.00729	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—IRS2—polycystic ovary syndrome	0.000465	0.00725	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Ovarian Infertility Genes—NCOR1—polycystic ovary syndrome	0.000465	0.00725	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—LEP—polycystic ovary syndrome	0.000455	0.0071	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—LIF—polycystic ovary syndrome	0.000451	0.00704	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—RETN—polycystic ovary syndrome	0.000451	0.00704	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000449	0.00701	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000443	0.00692	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptors—NR3C1—polycystic ovary syndrome	0.000436	0.00679	CbGpPWpGaD
Cyproterone acetate—NR3C1—Circadian Clock—NAMPT—polycystic ovary syndrome	0.00043	0.00671	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Endogenous sterols—POMC—polycystic ovary syndrome	0.000428	0.00667	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000421	0.00656	CbGpPWpGaD
Cyproterone acetate—Medroxyprogesterone Acetate—AR—polycystic ovary syndrome	0.000421	0.0613	CrCbGaD
Cyproterone acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000418	0.00652	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—PGR—polycystic ovary syndrome	0.000415	0.00648	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—ZNF430—polycystic ovary syndrome	0.000413	0.00645	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—ZNF205—polycystic ovary syndrome	0.000413	0.00645	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000412	0.00643	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptors—AR—polycystic ovary syndrome	0.000409	0.00637	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—IRS1—polycystic ovary syndrome	0.000406	0.00633	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—NCOR1—polycystic ovary syndrome	0.000397	0.00619	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—PPARG—polycystic ovary syndrome	0.000396	0.00618	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—polycystic ovary syndrome	0.000395	0.00616	CbGpPWpGaD
Cyproterone acetate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOR1—polycystic ovary syndrome	0.000365	0.00569	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000364	0.00568	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—NR3C1—polycystic ovary syndrome	0.000344	0.00537	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000339	0.00528	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptors—PPARG—polycystic ovary syndrome	0.000337	0.00526	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—NR3C1—polycystic ovary syndrome	0.000334	0.00521	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TCF7L2—polycystic ovary syndrome	0.00033	0.00515	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.00033	0.00514	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—AR—polycystic ovary syndrome	0.000323	0.00504	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—polycystic ovary syndrome	0.000321	0.005	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—ZNF205—polycystic ovary syndrome	0.000314	0.00489	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—ZNF430—polycystic ovary syndrome	0.000314	0.00489	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—AR—polycystic ovary syndrome	0.000313	0.00488	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.000308	0.0048	CbGpPWpGaD
Cyproterone acetate—AR—FOXA1 transcription factor network—INS—polycystic ovary syndrome	0.000294	0.00459	CbGpPWpGaD
Cyproterone acetate—Medroxyprogesterone Acetate—NR3C1—polycystic ovary syndrome	0.000285	0.0415	CrCbGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TH—polycystic ovary syndrome	0.000282	0.00439	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TCF7L2—polycystic ovary syndrome	0.000279	0.00435	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.000275	0.00428	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—PPARG—polycystic ovary syndrome	0.000267	0.00416	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000266	0.00416	CbGpPWpGaD
Cyproterone acetate—NR3C1—Circadian Clock—NCOR1—polycystic ovary syndrome	0.000266	0.00414	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000263	0.0041	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—NCOR1—polycystic ovary syndrome	0.000257	0.00401	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptors—PPARG—polycystic ovary syndrome	0.000256	0.00399	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—NCOR1—polycystic ovary syndrome	0.000238	0.00372	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—polycystic ovary syndrome	0.000238	0.00371	CbGpPWpGaD
Cyproterone acetate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—polycystic ovary syndrome	0.000236	0.00367	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000234	0.00365	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.000234	0.00364	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—PRL—polycystic ovary syndrome	0.00023	0.00359	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—TEAD2—polycystic ovary syndrome	0.000227	0.00353	CbGpPWpGaD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—polycystic ovary syndrome	0.000223	0.00348	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—polycystic ovary syndrome	0.000223	0.00348	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000218	0.00341	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—NAMPT—polycystic ovary syndrome	0.000216	0.00337	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000216	0.00337	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000215	0.00336	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000207	0.00323	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—LMNA—polycystic ovary syndrome	0.000205	0.0032	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—ATF1—polycystic ovary syndrome	0.000204	0.00318	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—PPARG—polycystic ovary syndrome	0.000202	0.00315	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—ZNF205—polycystic ovary syndrome	0.000199	0.0031	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—ZNF430—polycystic ovary syndrome	0.000199	0.0031	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000199	0.0031	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.000196	0.00305	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—polycystic ovary syndrome	0.000195	0.00304	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000194	0.00302	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000191	0.00298	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.00019	0.00297	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—BAX—polycystic ovary syndrome	0.000188	0.00293	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—TAB1—polycystic ovary syndrome	0.000188	0.00293	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CYP19A1—polycystic ovary syndrome	0.000184	0.00286	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00018	0.00281	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00018	0.00281	CbGpPWpGaD
Cyproterone acetate—Migraine—Metformin—polycystic ovary syndrome	0.000179	0.0403	CcSEcCtD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000177	0.00277	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—ADIPOQ—polycystic ovary syndrome	0.000177	0.00276	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—ATF1—polycystic ovary syndrome	0.000175	0.00273	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—TEAD2—polycystic ovary syndrome	0.000172	0.00268	CbGpPWpGaD
Cyproterone acetate—NR3C1—Circadian Clock—SERPINE1—polycystic ovary syndrome	0.000172	0.00268	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—IL6—polycystic ovary syndrome	0.00017	0.00265	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—ADARB1—polycystic ovary syndrome	0.000169	0.00264	CbGpPWpGaD
Cyproterone acetate—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.000168	0.0378	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—SLC2A4—polycystic ovary syndrome	0.000167	0.0026	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—polycystic ovary syndrome	0.000166	0.00259	CbGpPWpGaD
Cyproterone acetate—Breast disorder—Metformin—polycystic ovary syndrome	0.000165	0.037	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000164	0.00256	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000164	0.00256	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—TAB1—polycystic ovary syndrome	0.000162	0.00252	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000161	0.00251	CbGpPWpGaD
Cyproterone acetate—Pancreatitis—Metformin—polycystic ovary syndrome	0.000155	0.0347	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—AR—polycystic ovary syndrome	0.000154	0.0024	CbGpPWpGaD
Cyproterone acetate—Sweating increased—Metformin—polycystic ovary syndrome	0.000154	0.0345	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—BAX—polycystic ovary syndrome	0.000152	0.00237	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—ZNF205—polycystic ovary syndrome	0.000151	0.00236	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—ZNF430—polycystic ovary syndrome	0.000151	0.00236	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.000148	0.00231	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.000141	0.00219	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—LSM5—polycystic ovary syndrome	0.000138	0.00215	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000137	0.00214	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—POMC—polycystic ovary syndrome	0.000136	0.00213	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—NCOR1—polycystic ovary syndrome	0.000134	0.00208	CbGpPWpGaD
Cyproterone acetate—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.000133	0.0299	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.000132	0.00206	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—BAX—polycystic ovary syndrome	0.000131	0.00204	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00013	0.00203	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—ADARB1—polycystic ovary syndrome	0.000128	0.002	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—SAP30L—polycystic ovary syndrome	0.000128	0.002	CbGpPWpGaD
Cyproterone acetate—Hepatitis—Metformin—polycystic ovary syndrome	0.000126	0.0284	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000126	0.00197	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—polycystic ovary syndrome	0.000126	0.00196	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000124	0.00194	CbGpPWpGaD
Cyproterone acetate—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.000124	0.0279	CcSEcCtD
Cyproterone acetate—Eye disorder—Metformin—polycystic ovary syndrome	0.000118	0.0265	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000115	0.00179	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—IRS1—polycystic ovary syndrome	0.000115	0.00179	CbGpPWpGaD
Cyproterone acetate—Angiopathy—Metformin—polycystic ovary syndrome	0.000114	0.0257	CcSEcCtD
Cyproterone acetate—Immune system disorder—Metformin—polycystic ovary syndrome	0.000114	0.0256	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.000114	0.0256	CcSEcCtD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000113	0.00177	CbGpPWpGaD
Cyproterone acetate—Chills—Metformin—polycystic ovary syndrome	0.000113	0.0254	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—IRS2—polycystic ovary syndrome	0.000112	0.00175	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—LEP—polycystic ovary syndrome	0.00011	0.00171	CbGpPWpGaD
Cyproterone acetate—Malnutrition—Metformin—polycystic ovary syndrome	0.00011	0.0247	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—TEAD2—polycystic ovary syndrome	0.000109	0.0017	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	0.000108	0.00169	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000106	0.00165	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—LSM5—polycystic ovary syndrome	0.000105	0.00163	CbGpPWpGaD
Cyproterone acetate—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000102	0.0229	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000101	0.00157	CbGpPWpGaD
Cyproterone acetate—Malaise—Metformin—polycystic ovary syndrome	9.9e-05	0.0223	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—IRS1—polycystic ovary syndrome	9.86e-05	0.00154	CbGpPWpGaD
Cyproterone acetate—Syncope—Metformin—polycystic ovary syndrome	9.85e-05	0.0221	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—IRS1—polycystic ovary syndrome	9.8e-05	0.00153	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—SAP30L—polycystic ovary syndrome	9.73e-05	0.00152	CbGpPWpGaD
Cyproterone acetate—Loss of consciousness—Metformin—polycystic ovary syndrome	9.65e-05	0.0217	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	9.63e-05	0.0015	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—PPARG—polycystic ovary syndrome	9.57e-05	0.00149	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—PGR—polycystic ovary syndrome	9.45e-05	0.00147	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	9.41e-05	0.00147	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—INS—polycystic ovary syndrome	9.39e-05	0.00146	CbGpPWpGaD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	9.28e-05	0.0209	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—BCL2—polycystic ovary syndrome	9.27e-05	0.00145	CbGpPWpGaD
Cyproterone acetate—Discomfort—Metformin—polycystic ovary syndrome	9.24e-05	0.0208	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—SUOX—polycystic ovary syndrome	9.23e-05	0.00144	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—LPCAT2—polycystic ovary syndrome	9.23e-05	0.00144	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	9.12e-05	0.00142	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—IGF1—polycystic ovary syndrome	9.08e-05	0.00142	CbGpPWpGaD
Cyproterone acetate—Oedema—Metformin—polycystic ovary syndrome	8.96e-05	0.0201	CcSEcCtD
Cyproterone acetate—Shock—Metformin—polycystic ovary syndrome	8.82e-05	0.0198	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	8.8e-05	0.00137	CbGpPWpGaD
Cyproterone acetate—Nervous system disorder—Metformin—polycystic ovary syndrome	8.79e-05	0.0198	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Metformin—polycystic ovary syndrome	8.77e-05	0.0197	CcSEcCtD
Cyproterone acetate—Skin disorder—Metformin—polycystic ovary syndrome	8.7e-05	0.0196	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Metformin—polycystic ovary syndrome	8.66e-05	0.0195	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—SERPINE1—polycystic ovary syndrome	8.62e-05	0.00134	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ISYNA1—polycystic ovary syndrome	8.58e-05	0.00134	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—POMC—polycystic ovary syndrome	8.56e-05	0.00133	CbGpPWpGaD
Cyproterone acetate—Anorexia—Metformin—polycystic ovary syndrome	8.54e-05	0.0192	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	8.39e-05	0.00131	CbGpPWpGaD
Cyproterone acetate—Hypotension—Metformin—polycystic ovary syndrome	8.37e-05	0.0188	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—TEAD2—polycystic ovary syndrome	8.28e-05	0.00129	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	8.21e-05	0.00128	CbGpPWpGaD
Cyproterone acetate—Dyspnoea—Metformin—polycystic ovary syndrome	7.99e-05	0.018	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—BCL2—polycystic ovary syndrome	7.97e-05	0.00124	CbGpPWpGaD
Cyproterone acetate—Dyspepsia—Metformin—polycystic ovary syndrome	7.89e-05	0.0177	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	7.83e-05	0.00122	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Metformin—polycystic ovary syndrome	7.79e-05	0.0175	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—RPL37A—polycystic ovary syndrome	7.77e-05	0.00121	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	7.74e-05	0.0174	CcSEcCtD
Cyproterone acetate—Fatigue—Metformin—polycystic ovary syndrome	7.73e-05	0.0174	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	7.68e-05	0.0012	CbGpPWpGaD
Cyproterone acetate—Constipation—Metformin—polycystic ovary syndrome	7.66e-05	0.0172	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	7.43e-05	0.00116	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Metformin—polycystic ovary syndrome	7.38e-05	0.0166	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Metformin—polycystic ovary syndrome	7.33e-05	0.0165	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—TEAD2—polycystic ovary syndrome	7.3e-05	0.00114	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AKR1C2—polycystic ovary syndrome	7.3e-05	0.00114	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—PGR—polycystic ovary syndrome	7.17e-05	0.00112	CbGpPWpGaD
Cyproterone acetate—Urticaria—Metformin—polycystic ovary syndrome	7.12e-05	0.016	CcSEcCtD
Cyproterone acetate—Abdominal pain—Metformin—polycystic ovary syndrome	7.08e-05	0.0159	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	7.02e-05	0.00109	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—VEGFA—polycystic ovary syndrome	6.93e-05	0.00108	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	6.91e-05	0.00108	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	6.76e-05	0.00105	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL6—polycystic ovary syndrome	6.73e-05	0.00105	CbGpPWpGaD
Cyproterone acetate—Asthenia—Metformin—polycystic ovary syndrome	6.43e-05	0.0145	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	6.43e-05	0.001	CbGpPWpGaD
Cyproterone acetate—Pruritus—Metformin—polycystic ovary syndrome	6.34e-05	0.0143	CcSEcCtD
Cyproterone acetate—Diarrhoea—Metformin—polycystic ovary syndrome	6.13e-05	0.0138	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—PNPLA2—polycystic ovary syndrome	6.12e-05	0.000954	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—polycystic ovary syndrome	5.97e-05	0.00093	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	5.95e-05	0.000927	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL6—polycystic ovary syndrome	5.93e-05	0.000925	CbGpPWpGaD
Cyproterone acetate—Dizziness—Metformin—polycystic ovary syndrome	5.93e-05	0.0133	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—RPL37A—polycystic ovary syndrome	5.9e-05	0.00092	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SRD5A1—polycystic ovary syndrome	5.8e-05	0.000904	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	5.75e-05	0.000896	CbGpPWpGaD
Cyproterone acetate—Vomiting—Metformin—polycystic ovary syndrome	5.7e-05	0.0128	CcSEcCtD
Cyproterone acetate—Rash—Metformin—polycystic ovary syndrome	5.65e-05	0.0127	CcSEcCtD
Cyproterone acetate—Dermatitis—Metformin—polycystic ovary syndrome	5.65e-05	0.0127	CcSEcCtD
Cyproterone acetate—Headache—Metformin—polycystic ovary syndrome	5.61e-05	0.0126	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—AR—polycystic ovary syndrome	5.58e-05	0.00087	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—STAR—polycystic ovary syndrome	5.53e-05	0.000863	CbGpPWpGaD
Cyproterone acetate—Nausea—Metformin—polycystic ovary syndrome	5.32e-05	0.012	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—YAP1—polycystic ovary syndrome	5.21e-05	0.000813	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	5.12e-05	0.000799	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HMMR—polycystic ovary syndrome	4.93e-05	0.000769	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	4.88e-05	0.00076	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HSD3B1—polycystic ovary syndrome	4.7e-05	0.000733	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	4.67e-05	0.000729	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	4.65e-05	0.000725	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	4.61e-05	0.000718	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—TNRC6B—polycystic ovary syndrome	4.6e-05	0.000717	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PGR—polycystic ovary syndrome	4.55e-05	0.00071	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	4.41e-05	0.000687	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—LHB—polycystic ovary syndrome	4.29e-05	0.000669	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HSD3B2—polycystic ovary syndrome	4.19e-05	0.000654	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	4.15e-05	0.000647	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—IL6—polycystic ovary syndrome	4.1e-05	0.00064	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AKR1C1—polycystic ovary syndrome	4.06e-05	0.000633	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—YAP1—polycystic ovary syndrome	3.95e-05	0.000617	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SULT2A1—polycystic ovary syndrome	3.74e-05	0.000583	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—RRM2—polycystic ovary syndrome	3.62e-05	0.000564	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	3.54e-05	0.000553	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	3.49e-05	0.000545	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—TNRC6B—polycystic ovary syndrome	3.49e-05	0.000544	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—YAP1—polycystic ovary syndrome	3.49e-05	0.000544	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PGR—polycystic ovary syndrome	3.45e-05	0.000539	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NAMPT—polycystic ovary syndrome	3.35e-05	0.000523	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	3.33e-05	0.00052	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP11A1—polycystic ovary syndrome	3.31e-05	0.000516	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	3.29e-05	0.000512	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	3.15e-05	0.000491	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AKR1C3—polycystic ovary syndrome	3.13e-05	0.000487	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NCOR1—polycystic ovary syndrome	3.09e-05	0.000483	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP17A1—polycystic ovary syndrome	3.08e-05	0.00048	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NR3C1—polycystic ovary syndrome	2.86e-05	0.000446	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—AR—polycystic ovary syndrome	2.69e-05	0.000419	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—TH—polycystic ovary syndrome	2.66e-05	0.000415	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLC2A4—polycystic ovary syndrome	2.59e-05	0.000404	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NCOR1—polycystic ovary syndrome	2.35e-05	0.000366	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PPARG—polycystic ovary syndrome	2.22e-05	0.000346	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GNAS—polycystic ovary syndrome	2.17e-05	0.000339	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NCOR1—polycystic ovary syndrome	2.07e-05	0.000323	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—SERPINE1—polycystic ovary syndrome	2e-05	0.000312	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP1A1—polycystic ovary syndrome	1.96e-05	0.000306	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MTHFR—polycystic ovary syndrome	1.83e-05	0.000285	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PPARG—polycystic ovary syndrome	1.68e-05	0.000262	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—SERPINE1—polycystic ovary syndrome	1.52e-05	0.000236	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PPARG—polycystic ovary syndrome	1.48e-05	0.000231	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—POMC—polycystic ovary syndrome	1.46e-05	0.000228	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—INS—polycystic ovary syndrome	1.46e-05	0.000227	CbGpPWpGaD
